These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


348 related items for PubMed ID: 14609922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. AREDS--two years later.
    Jampol LM.
    Arch Ophthalmol; 2003 Nov; 121(11):1634-6. PubMed ID: 14609925
    [No Abstract] [Full Text] [Related]

  • 3. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group.
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [Abstract] [Full Text] [Related]

  • 4. Impact of AREDS in a developing country 5 years after publication of the study.
    Fahed DC, Ghazi NG, Jabbour NM, Fahed CD, Fahed JC, Salti HI.
    Eur J Ophthalmol; 2011 Oct; 21(1):67-72. PubMed ID: 20602323
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group.
    JAMA; 2013 May 15; 309(19):2005-15. PubMed ID: 23644932
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P.
    Ophthalmology; 2008 Feb 15; 115(2):334-41. PubMed ID: 17664009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [AREDS and age-related macular degeneration].
    Asensio Sánchez VM.
    Arch Soc Esp Oftalmol; 2002 Sep 15; 77(9):477; author reply 477-9. PubMed ID: 12221538
    [No Abstract] [Full Text] [Related]

  • 14. The age-related eye disease study: the results of the clinical trial.
    Sackett CS, Schenning S.
    Insight; 2002 Sep 15; 27(1):5-7. PubMed ID: 11962062
    [Abstract] [Full Text] [Related]

  • 15. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL, Roach JM.
    Consult Pharm; 2013 Nov 15; 28(11):723-37. PubMed ID: 24217192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.
    Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL, Age-Related Eye Disease Study Research Group.
    Ophthalmology; 2005 Apr 15; 112(4):533-9. PubMed ID: 15808240
    [Abstract] [Full Text] [Related]

  • 20. Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.
    Bartlett H, Eperjesi F.
    Ophthalmic Physiol Opt; 2003 Sep 15; 23(5):383-99. PubMed ID: 12950886
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.